Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.

PubWeight™: 1.06‹?› | Rank: Top 10%

🔗 View Article (PMC 4256936)

Published in Respir Res on August 06, 2014

Authors

Emily S Wan, Peter J Castaldi, Michael H Cho, John E Hokanson, Elizabeth A Regan, Barry J Make, Terri H Beaty, MeiLan K Han, Jeffrey L Curtis, Douglas Curran-Everett, David A Lynch, Dawn L DeMeo, James D Crapo, Edwin K Silverman, COPDGene Investigators

Associated clinical trials:

Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (COPDGene) | NCT00608764

NCT00060876

Articles citing this

Clinical and Radiologic Disease in Smokers With Normal Spirometry. JAMA Intern Med (2015) 1.61

Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 1.07

Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet (2015) 0.92

Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.92

Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study. Respir Res (2015) 0.84

Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults. Contemp Clin Trials (2016) 0.81

Obesity is Associated with Increased Morbidity in Moderate to Severe COPD. Chest (2016) 0.79

The impact of genetic variation and cigarette smoke on DNA methylation in current and former smokers from the COPDGene study. Epigenetics (2015) 0.79

Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. Am J Respir Crit Care Med (2016) 0.78

Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.77

Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort. Genet Epidemiol (2015) 0.76

Pulmonary Predictors of Incident Diabetes in Smokers. Chronic Obstr Pulm Dis (2016) 0.75

Hemizygous Deletion on Chromosome 3p26.1 Is Associated with Heavy Smoking among African American Subjects in the COPDGene Study. PLoS One (2016) 0.75

Acute Exacerbations and Lung Function Loss in Smokers With and Without COPD. Am J Respir Crit Care Med (2016) 0.75

Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. Respir Res (2016) 0.75

Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs. Allergy Asthma Clin Immunol (2016) 0.75

Visual Assessment of Chest CT Images is Independently Useful for Genetic Association Analysis in Studies of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2016) 0.75

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

A map of human genome variation from population-scale sequencing. Nature (2010) 121.13

Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol (2010) 26.41

METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (2010) 21.21

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81

Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med (2011) 4.75

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003. COPD (2004) 3.14

The effects of body mass index on lung volumes. Chest (2006) 2.95

Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm (2010) 2.79

Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med (2003) 2.53

Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax (2010) 2.43

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med (2006) 2.29

Lessons from the World Trade Center disaster: airway disease presenting as restrictive dysfunction. Chest (2013) 2.12

How accurate is spirometry at predicting restrictive pulmonary impairment? Chest (1999) 2.06

Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry. Eur Respir J (2013) 1.93

Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76

Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55

Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis (2005) 1.50

Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med (2003) 1.50

Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48

Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest (2013) 1.44

Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab (2005) 1.36

Lung function in type 2 diabetes: the Normative Aging Study. Respir Med (2005) 1.26

Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab (2004) 1.17

Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J Mol Cell Cardiol (2009) 1.11

High prevalence of genetic variants previously associated with Brugada syndrome in new exome data. Clin Genet (2013) 1.08

Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest (2011) 1.07

Usefulness of GOLD classification of COPD severity. Thorax (2003) 1.06

Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity. Chest (2004) 0.97

The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest (2010) 0.96

Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity. Eur Respir J (2007) 0.96

Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J (2012) 0.91

Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2010) 0.90

Respiratory impairment and mortality in older persons: a novel spirometric approach. J Investig Med (2011) 0.89

John Hutchinson's mysterious machine revisited. Chest (2002) 0.83

Identification and characterization of splicing variants of PLEKHA5 (Plekha5) during brain development. Gene (2011) 0.82

Pericardial fat is associated with impaired lung function and a restrictive lung pattern in adults: the Jackson Heart Study. Chest (2011) 0.82

Klinefelter's syndrome and pulmonary disease. Am Rev Respir Dis (1968) 0.79

Pathogenesis of the lung in restrictive defects of Klinefelter's syndrome. Chest (1992) 0.77

Restrictive defect in Klinefelter's syndrome. Chest (1982) 0.76

Pulmonary function in Klinefelter's syndrome. Chest (1981) 0.76

Articles by these authors

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39

Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66

Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93

Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology (2012) 6.92

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82

Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71

Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet (2009) 6.36

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33

Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med (2011) 5.69

Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol (2004) 5.57

Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54

Genomic screening and replication using the same data set in family-based association testing. Nat Genet (2005) 5.44

Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42

Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet (2011) 5.41

Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17

Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med (2011) 4.75

PBAT: tools for family-based association studies. Am J Hum Genet (2004) 4.68

Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65

The PhenX Toolkit: get the most from your measures. Am J Epidemiol (2011) 4.19

Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19

Variants of DENND1B associated with asthma in children. N Engl J Med (2009) 4.18

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98

Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97

MMP12, lung function, and COPD in high-risk populations. N Engl J Med (2009) 3.96

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92

A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet (2009) 3.78

Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71

Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68

Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65

A multivariate family-based association test using generalized estimating equations: FBAT-GEE. Biostatistics (2003) 3.52

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51

The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48

Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet (2010) 3.44

Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44

Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet (2009) 3.41

On the replication of genetic associations: timing can be everything! Am J Hum Genet (2008) 3.32

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 3.23

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17

Power and design considerations for a general class of family-based association tests: quantitative traits. Am J Hum Genet (2002) 2.96

The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med (2007) 2.91

Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax (2013) 2.88

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) (2007) 2.83

Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80

Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77

Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum (2011) 2.74

Meta-analysis of 13 genome scans reveals multiple cleft lip/palate genes with novel loci on 9q21 and 2q32-35. Am J Hum Genet (2004) 2.65

Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med (2004) 2.62

A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol (2009) 2.53

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes (2003) 2.51

Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst (2010) 2.50

Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med (2003) 2.49

Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging (2010) 2.48